共 225 条
[1]
Juliusson G(2009)Age and acute myeloid leukemia: real world data on decision to treat and outcomes from the Swedish Acute Leukemia Registry Blood 113 4179-4187
[2]
Antunovic P(1992)An overview of quality of life assessments and outcome measures Br J Med Econ 4 1-7
[3]
Derolf A(1997)Acute myeloid leukemia in the elderly: assessment of multidrug resistance (MDR1) and cytogenetics distinguishes biologic subgroups with remarkably distinct responses to standard chemotherapy. A Southwest Oncology Group Study Blood 89 3323-3329
[4]
Lehmann S(2003)Acute myeloid leukemia and acute promyelocytic leukemia Hematology 2003 82-101
[5]
Mollgard L(2004)Aurora kinases link chromosome segregation and cell division to cancer susceptibility Curr Opin Genet Dev 14 29-36
[6]
Stockelberg D(2008)Modeling the temporal evolution of the spindle assembly checkpoint and role of Aurora B kinase Proc Natl Acad Sci USA 105 20215-20220
[7]
Tidefelt U(2005)Aurora-B/AIM-1 kinase activity is involved in Ras-mediated cell transformation Oncogene 24 7266-7272
[8]
Wahlin A(2002)Increased mitotic phosphorylation of histone H3 attributable to AIM-1/Aurora-B overexpression contributes to chromosome number instability Cancer Res 62 5168-5177
[9]
Hoglund M(2007)A novel treatment strategy targeting Aurora kinases in acute myelogenous leukemia Mol Cancer Ther 6 1851-1857
[10]
Lovatt B(2007)AZD1152, a novel and selective aurora B kinase inhibitor, induces growth arrest, apoptosis, and sensitization for tubulin depolymerizing agent or topoisomerase II inhibitor in human acute leukemia cells in vitro and in vivo Blood 110 2034-2040